An artificial intelligence (AI) based model called Integrated Radiogenomics for Ovarian Neoadjuvant therapy (IRON) has been developed to predict the therapy outcome, measured by volumetric reduction of tumour lesions, in 80 percent of high-grade ovarian cancer patients. The technology is significantly better than current clinical methods with an accuracy of 80 percent. It …
HEALTH DAILY NEWS
Health News, Medical News, Medical conditions, Medical Tests & Procedures, Symptoms, Medical Diagnosis , Health Information, FDA alerts, Drug Watch, Product Watch, Medicine Articles, Welfare, Living